Congruence Therapeutics
Operator of a computationally-driven biotechnology company intended to discover novel drugs. The company uses structural bioinformatics, computational chemistry, and machine learning to design new pha...
Valuation
$0
Share Price
N/A
Total Raised
$97M
Last Round
N/A